Pfizer

Trump Announces TrumpRx: Discount Drugs Site Sparks Controversy

President Trump unveiled a comprehensive plan to lower drug costs, including a “TrumpRx” website for discounted medication purchases and an agreement with Pfizer. Pfizer has agreed to offer “Most Favored Nation” pricing in Medicaid, alongside significant price reductions for certain drugs via the new website. The administration also aims to have drug manufacturers sell directly to consumers, but industry experts remain skeptical about the impact. Critics worry these measures could shift prices internationally, raising prices elsewhere while potentially providing limited savings for consumers.

Read More

Pfizer Vaccine for Young Children: FDA Review Fuels Controversy Amidst Political Donations and Doubts

According to an email, the FDA may not renew Pfizer’s pediatric Covid vaccine authorization for the upcoming respiratory season, potentially removing the only vaccine for children under five. This decision would necessitate Moderna to increase its supply, although its vaccine is currently only approved for children with specific health conditions. The CDC is actively engaged in discussions with Moderna, focusing on addressing possible supply gaps and ensuring availability. This development occurs amid already low vaccination rates for children and ongoing concerns about the long-term effects of Covid.

Read More